In a report released yesterday, Faisal Khurshid from Leerink Partners reiterated a Buy rating on Kymera Therapeutics (KYMR – Research ...

Leerink Partners analyst Jonathan Chang maintained a Buy rating on Molecular Partners (MOLN – Research Report) on October 22. The ...

The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company ...

On Thursday, Progyny Inc (PGNY) stock saw a decline, ending the day at $15.55 which represents a decrease of $-0.31 or -1.95% from the prior close of $15.86. The stock opened at $15.84 and touched a ...

On Thursday, Certara Inc (CERT) stock saw a decline, ending the day at $10.12 which represents a decrease of $-0.42 or -3.98% from the prior close of $10.54. The stock opened at $10.56 and touched a ...

Pfizer and Merck's pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up ...

Still, Labcorp, cut the top-end of its 2024 adjusted profit forecast to $14.70 per share from $14.90, due to an impact of ...

Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been given a consensus recommendation of “Hold” by ...

EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares ...

Dentsply Sirona said on Thursday it was voluntarily suspending sales and marketing of its Byte teeth aligners and Impression Kits as it conducts a review of certain regulatory requirements related to ...

Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate sa ...